Dendritic Cells

After all, how do cancer cells get killed?

Special receptors, located on the surface of T-lymphocytes, recognize the antigens (which are various peptides), which are attached to the dendritic cells (ie the proteins of the major tissue compatibility system, which are located on the surface of the dendritic cells). The peptide binding proteins (type I and II) found there interact with CD4 + type T-lymphocytes, causing them to either differentiate into cytotoxic T-lymphocytes (if they are type I binding proteins) or to helper T-cells (lymphocytes). (if they are type II binding proteins).

In the case of treatment with dendritic cells, we are interested in producing several cytotoxic T-lymphocytes, because these will eventually recognize and destroy all the cancer cells that express this specific antigenicity.

- What is the treatment with dendritic cells (DK)?
- Is there a relationship between dendritic cells and oncothermia?
- What are dendritic cells?